NORML

MARCH 19, 2019

She generated international headlines when she opened the World Famous Cannabis Cafe in 2009, the nation’s first public-facing cannabis consumption lounge. “I would sum up our policy as ‘do the right thing’ Let’s create legal cannabis policy that acknowledges both science and reality,” Bacca says.

Legalization 191

Legalization Consumption Patients Policy 191

Cannabis Law Report

SEPTEMBER 24, 2021

Paul Armentano, deputy director of the cannabis advocacy group NORML, noted that veterans self-report cannabis use at higher rates than the general population. The 2009 law ranks as the first in the United States to specifically added PTSD to the list of conditions the state allowed cannabis to treat. appeared first on Dispensaries.

Marijuana 52

Marijuana Events Conditions Advocacy 52

Cannabis Law Report

SEPTEMBER 27, 2021

With this in mind, one focus of our extensive corporate social responsibility program is eliminating policies, practices, attitudes, actions and cultural messages that reinforce differential outcomes based on race. Boulder, Colorado-based Terrapin is a minority-owned business in operation since 2009.

Advocacy 52

Advocacy Policy Programs Cannabis 52

SpeedWeed

MARCH 19, 2021

Also, in 2009, New Zealand became the first country to accept ibogaine as a medication. These developments came after yearlong campaigns by advocacy groups and publicly traded companies who worked with the health ministry to encourage better access to psilocybin and other hallucinogens.

Environment 52

Environment Decriminalization Research and Development Advocacy 52

Cannabis Law Report

JUNE 4, 2021

As the top executive at Dr. Bronner’s Magic Soaps, he has become known for his activism around a range of issues, especially fair trade, sustainable agriculture, animal rights, and drug policy reform. Originally a lawyer, Yang began working in startups and early stage growth companies as a founder or executive from 2000 to 2009.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

NOVEMBER 24, 2021

These publications offer valuable indicators for current debates and disputes, political contestations, demands for reform or policy change, reactions to research activities and evidence, as well as attitudes from the medical profession towards new treatments and therapies like medicinal cannabis.

Research and Development 52

Research and Development Medicine Access Media 52